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Purpose: Evaluate the measurement properties of the StepWatch
TM
 Activity Monitor (SAM) 
and ActivPAL in COPD.  
Method: Whilst wearing both monitors, participants performed walking tasks at two self-
selected speeds, with and without a rollator. Steps obtained using the monitors were 
compared with that measured by direct observation. 
Results: Twenty participants aged 73±9 yr (FEV1=35±13%pred; 8 males) completed the 





, respectively. Agreement between steps recorded by the SAM with steps counted 
was similar irrespective of speed or rollator use (p=0.63) with a mean difference and limit of 
agreement (LOA) of 2 steps·min
-1
 and 6 steps·min
-1
, respectively. Agreement for the 
ActivPAL was worse at slow speeds (mean difference 7 steps·min
-1
; LOA 10 steps·min
-1
) 
compared with normal speeds (mean difference 4 steps·min
-1
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but was unaffected by rollator use. The change in step rate between slow and normal walking 
via direct observation was 12±7 steps·min
-1
 which was similar to that detected by the SAM 
(12±6 steps·min
-1
) and ActivPAL (14±7 steps·min
-1
).  
Conclusions: The SAM can be used to detect steps in people who walk very slowly 
including those who use a rollator. Both devices were sensitive to small changes. 























For people with chronic obstructive pulmonary disease (COPD), physical activity (PA) has 
evolved as an important outcome measure in the evaluation of interventions such as 
pulmonary rehabilitation.[1] It is defined as any bodily movement produced by skeletal 
muscles that results in energy expenditure beyond the resting state.[2] In people with COPD, 
the level of daily PA has been demonstrated to influence healthcare utilization, morbidity and 
mortality.[3, 4] Despite the importance of optimizing daily PA in this population, selecting an 
appropriate device to obtain valid measures remains a challenge. This is especially true for 
those individuals who walk slowly or use a rollator to assist with ambulation.[5-7] Earlier 
work has shown that activity monitors that attach to the waist underestimate PA in 
individuals who adopt slow walking speeds.[6-10] This is because slow walking produces 
movement of insufficient magnitude of the centre of mass to be detected by these devices. 
Measuring PA is particularly problematic in those who use a rollator to assist with 
ambulation.[6, 7] This is likely to relate to the slower walking speeds characteristic of people 
who require gait aids,[11] as well as alterations in the normal gait pattern.  
 
As slow walking diminishes movement in the limbs to a lesser extent than movement at the 
centre of mass,[11] we proposed that activity monitors which attach to the leg, rather than the 
waist, may yield accurate measures in people with COPD who are known to adopt slow 
walking cadences during daily life.[12] Following a review of the literature,[5, 9, 13-15] we 
decided to explore the measurement properties of two activity monitors that attached to the 
leg as they have yielded encouraging data in other clinical populations. Specifically, data 
reported by Resnick and colleagues[13] suggested that the StepWatch
TM
 Activity Monitor 
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(SAM; OrthocareInnovations, Seattle, Washington) may yield accurate measures of PA in 
individuals who walk slowly, including those who use a gait aid. This device attaches to the 
ankle. Similarly, the ActivPAL (PAL Technologies Ltd, Glasgow, Scotland), has been shown 
to yield accurate measures of PA in a healthy elderly population who walked at slow 
speeds.[15] This device attaches to the anterior aspect of the thigh. Both the SAM and 
ActivPAL are inexpensive, small, easily concealed by clothing and simple to use; features 
that make them attractive for monitoring PA in both the research and clinical setting.  
Nevertheless, the capacity of these devices to collect accurate information in people with 
COPD, who may use a rollator to assist with ambulation, is unknown. Further, the capacity of 
these devices to detect a small increase in PA is unknown. This is particularly important if 
these devices are used to evaluate the effect of therapies aimed at increasing PA in people 
with COPD.  
 
Therefore, the aims of this study were to; (i) explore the accuracy and responsiveness of the 
SAM and ActivPAL in people with COPD and, (ii) determine if using a rollator during 
ambulation impairs the performance of these devices. To achieve both of these aims, our gold 
standard measure was manual step counting via direct observation. The results of this study 
will assist healthcare professionals to select the most appropriate device to measure PA in 











A cross-sectional observational study was undertaken during which data collection for each 
participant was completed during a single one-hour session. The study was approved by the 




Participants were recruited from referrals to out-patient pulmonary rehabilitation programs. 
Inclusion criteria comprised of a diagnosis of COPD and functional limitation defined as a 
six-minute walk distance (6MWD) ≤ 450 m prior to rehabilitation. This 6MWD threshold 
was selected as it indicates an impairment in walking capacity when compared with the 
6MWD achieved by a population of healthy local Australians of similar age.[16] Individuals 




Once written informed consent was obtained, measurements were collected of height and 
weight. The most recent measurements of forced expiratory volume in one second (FEV1) 
and forced vital capacity (FVC) were extracted from the medical notes. The activity 
monitors, the SAM and ActivPAL, were attached to each participant. The participants then 
completed four constant-pace walking tasks, performed in a standardized order.  
 
Each walking task was performed for five minutes within a 20 m level, enclosed corridor. 
Tasks were separated by a 30-minute rest; a time period previously used to allow 
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cardiorespiratory responses to return to resting values between successive walking-based 
assessments of exercise capacity.[17] As this study did not aim to measure functional 
exercise capacity, there was no need to conduct these walking tasks over six minutes. The 
first two walking tasks were undertaken at a speed considered to be ‘slow’ by the participants 
with the final two walking tasks undertaken at a speed considered to be ‘normal’ by the 
participants. The first walk at both speeds was completed without a rollator and the second 
walk at both speeds was completed using a rollator.  
 
The process used to determine walking speeds and ensure that a constant pace was 
maintained has been described elsewhere.[7] This method was chosen to allow each 
participant to walk at an individualized slow and normal pace, which, in contrast to arbitrary 
walk speeds selected by the investigators, was more likely to be reflective of daily life.[7] 
Briefly, the time taken for each participant to; (i) walk for 40 m at a pace that they considered 
to be slow and, (ii) walk for 40 m at a pace that they considered to be normal were used to 
calculate the slow and normal walking speeds, respectively. Thereafter the 20 m corridor was 
marked at 5 m intervals with orange cones. The speed during each walking task was kept 
constant by using audio-signals that corresponded to a specific walking speed. That is, each 
audio-signal emitted a beep corresponding to when the participant needed to pass a cone in 
order to maintain the speed. The investigator walked with each participant for the first minute 
to provide verbal feedback regarding the use of the audio-signals. All participants were 
encouraged to maintain the pace dictated by the audio-signals, but to adopt a natural walking 
pattern. During each walking task, for each participant, the investigator counted the number 
of steps taken over three separate 30-second intervals (i.e. at the beginning of the second, 
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third and fourth minutes). The average of these three samples was used to determine the 
average step rate, for each participant, for each walking task.  
 




 Activity Monitor  
 
The SAM was attached to the participant’s right ankle using a Velcro strap. It is a small (75 × 
50 × 20 mm), light (38g) microprocessor controlled step counter that responds to time, 
acceleration and position. During the calibration procedure undertaken prior to data 
collection, the participant’s height was entered and the settings that pertained to ‘range of 
walking speed’ and ‘leg motion’ were selected as ‘moderate’ and ‘normal’, respectively. For 
each participant, the first 40 steps taken whilst wearing the SAM were observed to ensure that 
the device was detecting steps, as indicated by a flashing light emitting diode on heel 





The ActivPAL was attached to the anterior aspect of the participant’s thigh using a 10 cm by 
14 cm transparent film dressing (3M Tegaderm
TM
, 3M, St. Paul, Minnesota).   The device is a 
small (35 × 53 × 7 mm), light (20 g) uni-axial piezoresistive accelerometer. The ActivPAL 
has a sampling frequency of 10 Hz and data are available in fifteen-second epochs. 
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Data management and analysis:  
 
Raw data from the SAM and ActivPAL were exported to Microsoft Excel
®
 for further 
analyses. Data collected during the whole minutes of each walking task were averaged and 
converted into step rate. Analyses were performed using the Statistical Package for Social 
Sciences (SPSS version 17.0; Chicago, Illinois) with p < 0.05 used to denote statistical 




We used repeated measures analysis of variance (ANOVA) to examine the effect of rollator, 
walking speed and the interaction between the two, on the difference in step rate between 
SAM and direct observation. The same procedure was undertaken using data collected from 
the ActivPAL. Agreement analyses were undertaken according to the methods described by 




To determine if the SAM and ActivPAL could detect a difference in step rate between 
walking speeds with and without the rollator, a repeated measures ANOVA was used to 
examine the effect of rollator, walking speed and the interaction between the two, on step 
rate.  
 
Sample size calculation 
 




Prospective sample size calculations were conducted to attain a precision around our estimate 
of the limit of agreement ≤ 6 steps·min
-1
. This value was chosen as earlier work demonstrated 
that an increase of 12 steps·min
-1 
during self-selected walk tasks was perceived as the 
difference between slow and normal paced walking in people with COPD.[7] Therefore we 
speculated that a difference less than half this value would not be perceived as a different 
walking speed by the average person with COPD. Using data available in the literature, we 
estimated the SD of the difference to be 3 steps·min
-1 
(52 steps/20 minutes).[6] Using the 
methods described by Bland and Altman,[19] we determined that a sample size of 20 
participants was needed for the 95% confidence interval around the limit of agreement (LOA) 










Twenty-two participants consented to participate in this study. Data from two people were 
excluded as they were unable to complete the walking tasks without resting and therefore, 
their walking cadence was not constant during the tasks. All other participants were able to 
maintain a constant walking speed during each task (figure 1a-b) and there were no adverse 
events. The characteristics of the 20 participants who completed the study are summarized in 
table 1. Five (25%) people used a rollator in their home environment. Insert table 1 and  
figure 1a-b about here 
 
 







 Activity Monitor 
 
There was no interaction (rollator × walking speed; F1, 19 = 0.24; p = 0.63), effect of rollator 
(F1, 19 = 0.12; p = 0.73) or walking speed (F1, 19 = 0.03; p = 0.86) on the difference between 
step rate derived using the SAM and via direct observation. This indicated that the difference 
between step rate derived using the SAM and direct observation was similar across all 
walking tasks and therefore we grouped data from all four walks in the Bland-Altman 
analysis (figure 2). The mean difference (i.e. bias) between the step rate derived using the 
SAM and direct observation was 2 steps·min
-1
 with the LOA of 6 steps·min
-1
.  The upper and 
lower LOA occurred at 8 (95% confidence interval (CI); 6 to 9) and -4 (95% CI; -5 to -2) 
steps·min
-1




There was no interaction (rollator × walking speed; F1, 19 = 0.58; p = 0.46) or effect of rollator 
(F1, 19 = 0.01; p = 0.91) on the difference between step rate derived using the ActivPAL and 
direct observation. This indicates that the difference between the step rate derived using the 
ActivPAL and direct observation was not affected by the use of a rollator. However, there 
was a significant effect of walking speed (F1, 19 = 5.75; p = 0.03) on the difference between 
step rate derived using the ActivPAL and direct observation. This indicates that the difference 
between the step rate derived using the ActivPAL and direct observation differed between 
walking speeds and therefore, we prepared separate Bland-Altman plots for slow and normal 
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walking speeds (figure 3a and 3b, respectively). The mean difference (i.e. bias) in step rate 
derived using the ActivPAL and direct observation at slow walking speeds was 7 steps·min
-1 
with the LOA of 10 steps·min
-1
. The upper and lower LOA occurred at 17 (95% CI; 14 to 20) 
and -4 (95% confidence interval; -7 to -1) steps·min
-1
, respectively. The mean difference in 
step rate derived using the ActivPAL and direct observation at normal walking speeds was 4 
steps·min
-1
 and the LOA of 5 steps·min
-1
. The upper and lower LOA occurred at 10 (95% 




respectively. Insert figure 




For data collected using the SAM, there was no interaction (rollator × walking speed; F1, 19 = 
0.23; p = 0.63) but a significant effect of rollator (F1, 19 =12.39; p = 0.02) and walking speed 
(F1, 19 = 88.69; p < 0.01) on step rate. This indicates that the SAM was able to detect the 
difference in step rate associated with changing walking speeds and using a rollator. 
Likewise, for data collected using the ActivPAL, there was no interaction (rollator × walking 
speed; F1, 19 = 0.01; p = 0.93) but a significant effect of rollator (F1, 19 = 12.10; p = 0.003) and 
walking speed (F1, 19 = 102.86; p < 0.001) on step rate. This indicates that the ActivPAL was 
able to detect differences in step rate associated with changing walking speeds and using a 
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This is the first study to examine the measurement properties of the SAM and ActivPAL in 
individuals with COPD at two self-selected walking pace according to previous walking 
speed. Further, this study determined whether or not the use of a rollator to assist with 
ambulation affected the accuracy or responsiveness of these devices. The important findings 
of this study are; (i) the capacity of the SAM to detect steps was similar regardless of walk 
speed or rollator use, (ii) the capacity of the ActivPAL to detect steps was affected by walk 
speed but not rollator use and, (iii) both devices were able to detect small changes in step 
rate.  
 
Accuracy of the devices: 
 
A study by Pitta et al on 22 COPD patients found that these individuals tend to walk 1- to 2-
minute blocks over a 24-hour period,[20] thus the monitors we chose would be valid to 
measure PA in COPD patients. Our data reveal that the capacity of the SAM to measure step 
rate was similar at slow and normal walk speeds, regardless of whether or not a rollator was 
used. The mean difference between step rate derived using the SAM and direct observation 
was 2 steps·min
-1
, which is trivial compared with that reported for other commercially-
available for devices such as the Minimod, SenseWear armband and Digiwalker 
pedometer.[6, 21] The excellent agreement in step rate derived using the SAM and direct 
observation extends the findings of Resnick et al[13] who reported a strong correlation 
between these variables (r = 0.98) in a group of elderly people (aged 86 ± 6 yr) of whom 22 
(73%) used a walking aid to assist with ambulation. Although a strong correlation indicates 
that these measures were related, Bland-Altman analyses are needed to demonstrated 
agreement and therefore we report our results in terms of mean difference (i.e. bias) and 
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LOA. In contrast with the SAM, our data indicate that the capacity of the ActivPAL to detect 
steps was impaired at slow walking with the bias increasing from 4 to 7 steps·min
-1
 between 
normal and slow walking speeds, respectively. It is likely that the shorter stride lengths 
associated with walking at slower speeds[22] reduced movement at the thigh and thus 
impaired the capacity of the ActivPAL to detect steps. The shorter stride lengths will reduce 
movement at the ankle to a lesser extent; a factor that may explain why the SAM, which 
attaches to the ankle, had a similar capacity to detect steps at both walking speeds.[23] In 
addition to the position of the devices, the difference in the capacity of the SAM and 
ActivPAL to detect steps at the two walking speeds may also reflect the superior sampling 
frequency of the SAM (128 Hz) compared with the ActivPAL (10 Hz).  
 
Although our data indicates that the ActivPAL underestimated step rate at slow walk speeds, 
it is important to note that the walk speed selected by our participants for both the ‘normal’ 
(46 ± 10 m·min
-1
) and ‘slow’ (34 ± 6 m·min
-1
) walks was considerably slower than that used 
in other studies. For example, in the study by Langer et al,[6] the participant who walked the 
slowest at 42 m·min
-1
 was considered an outlier and excluded from the statistical analysis. In 
this individual, the Minimod underestimated step rate by approximately 39 steps·min
-1
, and 
SenseWear armband underestimated step rate by approximately 56 steps·min
-1
.[6] This 
compares favourably with our data, demonstrating that the ActivPAL underestimated step 
rate by 7 and 15 steps·min
-1
 with the rollator and 4 and 26 steps·min
-1
 without the rollator in 
the two individuals who walked the slowest (25 m·min
-1
) in our study; a speed considerably 
slower than the outlier in the study by Langer et al.[6] Therefore, although ActivPAL does 
underestimate steps at very slow walking speeds, it seems to outperform other popular, more 
expensive, commercially-available devices, such as the Minimod and SenseWear armband. 
 




An important and novel finding of our study is that the use of a rollator did not affect the 
capacity of the SAM or the ActivPAL to detect step rate. People with COPD who are 
characterized by a low 6MWD and marked dyspnea on exertion benefited from using a 
rollator both in terms of exercise capacity and reduction in dyspnea.[24, 25] Further, there is 
a high level of satisfaction associated with their use in the community.[26] Given the 
increasing use of rollators by people with COPD, it is important that clinicians and 
researchers are able to obtain accurate measures of PA in this subgroup. To our knowledge, 
this study is the first to identify two activity monitors that yield accurate measures of PA in 




For both activity monitors, there was a significant effect of walk speed, suggesting that the 
SAM and ActivPAL could detect the difference in step rate associated with changing from 
the slow to normal walk speed, regardless of whether the participant was using a rollator. The 
change in step rate between slow and normal walking, calculated via direct observation was 
12 ± 7 steps·min
-1
; a difference of similar magnitude as detected by the SAM (12 ± 6 
steps·min
-1
) and ActivPAL (14 ± 7 steps·min
-1
). A more impressive result is that there was a 
significant effect of rollator, suggesting that the SAM and ActivPAL could detect the trivial 
decrease in step rate associated with changing to use a rollator to assist with ambulation, 
regardless of walk speed. The change in step rate between using and not using the rollator, 
calculated via direct observation was 3 ± 3 steps·min
-1
; a difference of similar magnitude as 
detected by the SAM (3 ± 4 steps·min
-1
) and ActivPAL (3 ± 5 steps·min
-1
). Studies that have 
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examined the measurement properties of activity monitors usually focus on accuracy or 
validity of the devices. Our study extends earlier work [5, 9, 13-15] by confirming the 




We examine the measurement properties of the SAM and ActivPAL exclusively during 
walking tasks as this is a common activity of daily living.[3] We did not explore the 
measurement properties of these devices during other activities, such as cycling and also, did 
not determine the extent to which these devices may mis-classify movement associated with 




Both the SAM and ActivPAL underestimated step rates in the participants with COPD, 
however the difference was very small. Both devices were responsive to small changes in 
step rate. The SAM was accurate in detecting step rate regardless of walking speed or rollator 
use. In contrast, the accuracy of the ActivPAL to detect step rate was affected by walking 
speed but not rollator use. These devices can be used to assess physical activity in individuals 
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Figure 1: Step rate calculated using the three 30-second samples of direct observation 
for walking tasks undertaken at slow speed (1a) and normal speed (1b). Each subject 
contributed two lines to Figure 1a and 1b (i.e. for the walking task performed with and 
without the rollator). Also shown are the group mean (closed circles) and standard 
deviation (error bars) for the 1st and 3rd 30-second samples. Note the consistency in 
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Figure 2: Bland Altman plot for step rate obtained via direct observation and via the 
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Figure 3a 
a)       
 
Figure 3b           
b)           
 
 
Figure 3: Bland Altman plots for step rate obtained via direct observation and the 
ActivPAL at (a); slow walk speed (with and without rollator) and (b), normal walk 
speed (with and without rollator). 
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Table 1: Characteristics of study participants (n = 20; 8 males) 
Variable Mean ± SD 
Age, yr 73.0 ± 8.5 
Height, m  1.67 ± 0.09 
Weight, kg 69.0 ± 20.2 
Body mass index, kg·m
-2 
24.6 ± 6.2 
Long term oxygen therapy (n) 6 
FEV1, L 
 
0.84 ± 0.30 
FEV1 % predicted 35 ± 13 
FVC, L 
 
2.17 ± 0.63 
FVC% predicted 63 ± 20 
FEV1/FVC 40 ± 12 
6-minute walk distance, m 
 
338 ± 85 
6-minute walk distance predicted, %
† 
55 ± 14 
Slow walking speed, m·min
-1
 34 ± 6 
Normal walking speed, m·min
-1
 46 ± 10 
Modified MRC Dyspnea Grade (0 – 4)*  2.5 (2 – 3) 
BODE score* 4.5 (4 – 6) 
* Median (Inter quartile range) †Percent predicted based on formula obtained from Jenkins et al.21 
MRC, Medical Research Council; BODE, body mass index, airflow obstruction, dyspnea & exercise capacity 
index.  
 
Median time between participation in the study and most recent measurement of 6 minute walk distance and 
lung function and was one and four months, respectively. 
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Table 2: Step rates (in steps·min
-1
) for all walking tasks 
 Observed SAM ActivPAL 
Slow walk
*
 75 ± 8 73 ± 8
 
68 ± 11 
Normal walk
*
 85 ± 10 85 ± 10 83 ± 11 
Difference (normal - slow)
*
 12 ± 7

 12 ± 6






 83 ± 12 80 ± 11 74 ± 12 
Walk with rollator
†
 79 ±11 77 ± 10 77 ± 14 
Difference (without - with rollator)
†
 3 ± 3

 3 ± 4

 3 ± 5

 
Data are mean ± SD.  
*: includes data collected irrespective of whether a rollator was used. 
†: includes data collected irrespective of walking speed 
: denotes significance within group (p<0.001) 
 
 
 
 
 
 
 
 
 
